Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2010-03, Vol.102 (5), p.940-940
Hauptverfasser:	Mao, C, Liao, R-Y, Chen, Q
Format:	Artikel
Sprache:	eng
Schlagworte:	631/208/199 692/699/67/1504/1885 692/700/565/1436/2185 Antibodies, Monoclonal - pharmacology Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Colorectal Neoplasms - immunology Colorectal Neoplasms - secondary Colorectal Neoplasms - therapy Drug Resistance Epidemiology Gastroenterology. Liver. Pancreas. Abdomen Humans Letter to the Editor Medical sciences Meta-Analysis as Topic Molecular Medicine Oncology Prognosis PTEN Phosphohydrolase - deficiency Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptor, Epidermal Growth Factor - immunology Receptor, Epidermal Growth Factor - metabolism Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!